Nicolet Advisory Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.24M Buy
49,120
+6,583
+15% +$166K 0.08% 118
2025
Q3
$1.12M Sell
42,537
-265
-0.6% -$6.54K 0.09% 113
2025
Q2
$1.01M Buy
42,802
+4,157
+11% +$96.9K 0.09% 119
2025
Q1
$834K Buy
38,645
+6,410
+20% +$168K 0.08% 136
2024
Q4
$861K Sell
32,235
-8,263
-20% -$224K 0.08% 133
2024
Q3
$1.15M Buy
40,498
+451
+1% +$13.2K 0.11% 103
2024
Q2
$1.14M Buy
40,047
+5,616
+16% +$155K 0.11% 95
2024
Q1
$922K Buy
34,431
+2,951
+9% +$81.9K 0.09% 107
2023
Q4
$928K Sell
31,480
-3,142
-9% -$95K 0.1% 101
2023
Q3
$1.15M Buy
34,622
+293
+0.9% +$10.4K 0.13% 88
2023
Q2
$1.22M Sell
34,329
-1,206
-3% -$46.9K 0.13% 80
2023
Q1
$1.47M Buy
35,535
+7,341
+26% +$317K 0.17% 70
2022
Q4
$1.34M Buy
28,194
+3,172
+13% +$152K 0.18% 62
2022
Q3
$1.04M Buy
25,022
+2,472
+11% +$120K 0.17% 55
2022
Q2
$1.21M Buy
22,550
+656
+3% +$33.4K 0.18% 54
2022
Q1
$1.21M Buy
21,894
+868
+4% +$45K 0.16% 58
2021
Q4
$1.24M Sell
21,026
-2,046
-9% -$101K 0.15% 57
2021
Q3
$994K Buy
23,072
+422
+2% +$18.7K 0.13% 67
2021
Q2
$887K Buy
22,650
+851
+4% +$33.1K 0.12% 71
2021
Q1
$790K Sell
21,799
-142
-0.6% -$5.04K 0.11% 69
2020
Q4
$808K Sell
21,941
-1,055
-5% -$38.7K 0.11% 70
2020
Q3
$801K Sell
22,996
-5,777
-20% -$203K 0.12% 71
2020
Q2
$893K Buy
28,773
+497
+2% +$16.9K 0.14% 77
2020
Q1
$876K Buy
28,276
+9,844
+53% +$335K 0.15% 78
2019
Q4
$685K Buy
18,432
+4,016
+28% +$143K 0.11% 81
2019
Q3
$491K Buy
14,416
+1,769
+14% +$64.3K 0.07% 97
2019
Q2
$520K Sell
12,647
-316
-2% -$12.5K 0.08% 84
2019
Q1
$522K Buy
+12,963
New +$519K 0.09% 80

Other funds holding PFE

Nicolet Advisory Services's PFE Position: Q4 2025 in Review

Nicolet Advisory Services increased its Pfizer (PFE) stake by 15% in Q4 2025, buying an estimated $166K and bringing the position to 49,120 shares worth $1.24M. The position accounts for 0.08% of the portfolio, ranked #118.

Nicolet Advisory Services first reported a position in PFE in Q1 2019 and has held it in 28 quarters since. The position peaked at $1.47M in Q1 2023. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Nicolet Advisory Services held 49,120 shares of Pfizer worth $1.24M as of Q4 2025.
  • Nicolet Advisory Services bought 6,583 Pfizer shares in Q4 2025, an estimated $166K.
  • Pfizer made up 0.08% of Nicolet Advisory Services's portfolio in Q4 2025, its #118 holding.
  • Nicolet Advisory Services first reported a position in Pfizer in Q1 2019 and has held it in 28 quarters since.
  • Nicolet Advisory Services's Pfizer position peaked at $1.47M in Q1 2023.
  • 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Nicolet Advisory Services's 13F filing for Q4 2025, filed 13 Feb 2026.